| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 01/11/2007 | DE102005029704A1 Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik Use of hydrophobin polypeptides and conjugates of hydrophobin polypeptides with active or effect substances and their preparation and their use in cosmetics |
| 01/11/2007 | CA2848662A1 Il-12/p40 binding proteins |
| 01/11/2007 | CA2612239A1 Il-12/p40 binding proteins |
| 01/10/2007 | EP0812357B1 A method for making heteromultimeric polypeptides |
| 01/10/2007 | CN1893970A Beta-amyloid-analogue-cell epitop vaccine |
| 01/10/2007 | CN1891717A Chemical modification method of endostatin and its use |
| 01/09/2007 | US7161031 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 01/09/2007 | US7160993 Nucleic acids encoding PRO4400 polypeptides |
| 01/09/2007 | US7160864 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells |
| 01/09/2007 | US7160549 including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter |
| 01/09/2007 | CA2411019C Particles for immunoassays and methods for treating the same |
| 01/09/2007 | CA2141454C Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 01/04/2007 | WO2007002482A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 01/04/2007 | WO2007000972A1 Novel use as tag |
| 01/04/2007 | WO2007000163A1 Immobilisation of polypeptides by irradiation |
| 01/04/2007 | WO2006116319A3 Reagents that bind ccx-ckr2 |
| 01/04/2007 | WO2006017824A3 Igf-bp3-related methods for inhibiting tumor growth |
| 01/04/2007 | US20070004904 G-csf conjugates |
| 01/04/2007 | CA2613193A1 Thrombospondin-1 derived peptides and treatment methods |
| 01/04/2007 | CA2611964A1 Process for manufacturing vaccines |
| 01/03/2007 | EP1739090A2 Interferon-beta fusion proteins and uses |
| 01/03/2007 | EP1685245A4 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 01/03/2007 | EP1278534B1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/03/2007 | CN1887912A High activity golden mushroom polysaccharide-peptide-Fe chelate and its prepn |
| 01/02/2007 | US7157561 Methods of inhibiting transmission of a costimulatory signal of lymphocytes |
| 01/02/2007 | US7157556 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use |
| 01/02/2007 | US7157546 Water-soluble polymer alkanals |
| 01/02/2007 | US7157275 growing adherent cells using a cell adhesion promoting ("CAP") peptide covalently coupled to a cell adhesion resistant layer such as hyaluronic acid on a polystyrene surface to promote cell attachment, growth differentiation, in culture; biological scaffolds |
| 01/02/2007 | CA2134348C Polysaccharide derivatives and drug carriers |
| 12/28/2006 | WO2006138721A1 Anti-gfralpha3 antibodies |
| 12/28/2006 | WO2006138272A1 Metal ion-based immobilization |
| 12/28/2006 | WO2006102408A3 Methods and compositions for the modulation of immune responses and autoimmune diseases |
| 12/28/2006 | WO2004041067A3 Prevention and treatment of synucleinopathic disease |
| 12/28/2006 | CA2612417A1 Anti-gfralpha3 antibodies |
| 12/27/2006 | EP1734984A2 Compositions and methods for topical diagnostic and therapeutic transport |
| 12/27/2006 | EP1534740B1 Method for stabilising biomolecules |
| 12/27/2006 | EP1034273B1 Histamine and serotonin binding molecules |
| 12/27/2006 | CN1884298A Method for conserving antiseptic peptide using attachment method |
| 12/27/2006 | CN1883709A Bi-functional targeting antineoplastic polypeptide and application thereof |
| 12/26/2006 | US7153945 Peptide, novel adsorbent, adsorption unit and adsorption method |
| 12/26/2006 | US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair |
| 12/26/2006 | US7153682 Microarrays on mirrored substrates for performing proteomic analyses |
| 12/21/2006 | WO2006134379A1 Trityl derivatives for enhancing mass spectrometry |
| 12/21/2006 | WO2006113347A3 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products |
| 12/21/2006 | WO2006026355A3 Relaxin-chimeric polypeptides and their preparation and use |
| 12/21/2006 | WO2006010155A3 Gonadotropin releasing hormone antagonists |
| 12/21/2006 | WO2005062967A3 Novel anti-il 13 antibodies and uses thereof |
| 12/21/2006 | WO2004041172A3 Interferon antagonists useful for the treatment of interferon related diseases |
| 12/20/2006 | EP1733230A1 Assays for amphetamine and methamphetamine using stereospecific reagents |
| 12/20/2006 | EP1732963A2 High molecular weight polymer based on n,n-dimethylacrylamide |
| 12/20/2006 | EP1732596A2 Therapeutic use of rm1 antigen |
| 12/20/2006 | EP1687421A4 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 12/20/2006 | EP1481083B1 Detection of nucleic acids |
| 12/20/2006 | CN1882685A A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 12/20/2006 | CN1879877A Tumour-specific animal proteins |
| 12/19/2006 | US7151163 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 12/19/2006 | US7150967 Uisng fluorescent label; mercurimethyl dihydropsoralen |
| 12/14/2006 | WO2006131080A1 Protein microarrays for immunodiagnostics |
| 12/14/2006 | WO2005079390A3 Inhibition of fgf signaling |
| 12/14/2006 | WO2004108069A3 Compositions and methods for promoting neuronal outgrowth |
| 12/14/2006 | WO2004006861A3 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease |
| 12/14/2006 | US20060281087 Titanium dioxide complex having molecule distinguishability |
| 12/13/2006 | EP1731174A2 Polypeptides having a covalently bound N-terminal polyethylene glycol via hydrazone or oxime bond |
| 12/13/2006 | EP1730525A1 Immunoassays for everolimus |
| 12/13/2006 | CN1289528C Recombinant human interferon-alpha 1b compound and process for preparation |
| 12/12/2006 | US7148325 Preferential polypeptide for us e in the treatment of viral disesaes |
| 12/12/2006 | US7148190 Haptotactic peprides |
| 12/12/2006 | US7148058 Solid support for use in the detection of preferential protein complexes in sample |
| 12/12/2006 | US7148029 Generating antibodies; quantitative analysis |
| 12/12/2006 | US7148021 Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| 12/07/2006 | WO2006129796A1 Support for carrying magnetic particles and method of preparing the same |
| 12/07/2006 | WO2004074454A3 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 12/07/2006 | US20060276622 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 12/07/2006 | US20060276621 Glycosylated specificity exchangers |
| 12/06/2006 | EP1728802A2 ErbB3 antibodies |
| 12/06/2006 | EP1728516A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 12/06/2006 | EP0969865B1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 12/06/2006 | CN1875098A Carbohydrate-binding modules of a new family |
| 12/05/2006 | US7144987 Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders |
| 12/05/2006 | US7144574 For therapy of multiple sclerosis |
| 11/30/2006 | WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides |
| 11/30/2006 | WO2004047728A3 Compositions and methods for the treatment of immune related diseases |
| 11/30/2006 | US20060270829 G-csf conjugates |
| 11/29/2006 | EP1581645A4 Method for using division arrested cells in screening assays |
| 11/29/2006 | EP1412517B1 Methods, kits and compositions of combination oligomers |
| 11/29/2006 | EP1299724B1 Synthetic peptide for neurological disorders |
| 11/29/2006 | EP1108205B1 Azaftig, a proteoglycan for monitoring cachexia and for control of obesity |
| 11/29/2006 | CN1869692A Three-function nano-ball |
| 11/29/2006 | CN1869070A High efficiency low poison immune toxin and its preparation method and application |
| 11/28/2006 | US7141652 Antibodies to PRO1561 polypeptide |
| 11/23/2006 | WO2006084888A3 C-terminally pegylated growth hormones |
| 11/23/2006 | WO2005086967A3 Therapeutic use of rm1 antigen |
| 11/23/2006 | US20060264614 Diagnosis using inexpensive and reliable reagents; stimulate immune response; can be used to determine the susceptibility of a particular individual to a treatment regimen |
| 11/23/2006 | US20060264605 Polypeptides having anti-HIV activity and compositions comprising same |
| 11/23/2006 | US20060264604 Anti-HBs monoclonal antibody |
| 11/23/2006 | CA2609190A1 Methods for treating fibrotic conditions |
| 11/22/2006 | EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 11/21/2006 | US7138504 Reagents and methods for mycophenolic acid immunoassay |
| 11/21/2006 | US7138486 Insulinotropic hormone derivatives and uses thereof |
| 11/21/2006 | US7138244 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |